Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

More Resistance Levels Broken

Published 02/19/2019, 02:26 PM
Updated 07/09/2023, 06:31 AM

Valuation Moderating

All of the indexes closed higher Friday with positive internals on the NYSE and NASDAQ as volumes declined on the NYSE while those on the NASDAQ increased from the prior session. All but one of the charts broke above their near term resistance levels as all remain in uptrends. The data, while mostly neutral, finds the 1 day McClellan OB/OS Oscillators overbought. As well, forward earnings estimates for the SPX have been declining, suggesting it is closing in on fair value versus its prior undervalued status. Nonetheless, we have yet to see sufficient evidence to alter our near term “positive” outlook for the major equity indexes.

  • On the charts, all, of the indexes closed higher Friday with positive internals. The only index unable to close above its near term resistance level was the NDX (page 3) as the rest achieved that goal. As such, all of the index charts remain in near term uptrends as do the cumulative advance/decline lines for the All Exchange, NYSE and NASDAQ. Stochastic levels are overbought but have not flashed bearish crossover signals at this point.
  • The data remains mostly neutral although all of the McClellan OB/OS Oscillators are now overbought (All Exchange:+73.17/+98.28 NYSE:+78.34/+122.96 NASDAQ:+71.52/+79.31). While remaining in neutral territory, the Open Insider Buy/Sell Ratio (26.9) and % of SPX stocks trading above their 50 DMAs (89.7%) are close to turning negative. Yet we would note they are not great “timing” instruments for short term market shifts. Valuation may be the most important metric at this point as the forward 12 month earnings estimates for the SPX via Bloomberg has declined to $167.76 from $171.00 a few weeks ago, leaving the forward 12 month p/e for the SPX at 16.6 versus the “rule of 20” implied fair value of a 17.3 multiple. While still undervalued, we believe it worth noting as the spread between actual and fair value has been shrinking. Should the SPX continue to advance as estimates decline, it may prove problematic. The “earnings yield” stands at 6.04%.
  • In conclusion, while there are a few issues as discussed above that have us looking over our shoulders a bit, the state of the charts and data continue to suggest we maintain our near term “positive” outlook for the major equity indexes at this point in time..
  • SPX: 2,723/2,796
  • DJI: 25,290/25,882
  • Nasdaq: 7,236/7,501
  • NDX: 6,845/7,110
  • DJT: 10,298/10,675
  • MID: 1,864/1,917
  • Russell: 1,509/1,587
  • VALUA: 6,000/6,219

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.